Skip to main content
OPKO Health Inc. logo

OPKO Health Inc. — Investor Relations & Filings

Ticker · OPK ISIN · US68375N1037 LEI · 529900A4S2D4OGOJLL02 TA Human health and social work activities
Open in API
Filings indexed 3,780 across all filing types
Latest filing 2026-03-19 Board/Management Inform…
Country US United States of America
Listing TA OPK

About OPKO Health Inc.

https://www.opko.com

OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.

Recent filings

Filing Released Lang Actions
Immediate Report
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC. Item 5.02 specifically details the appointment of a new director, Subbarao V. Uppaluri, to the Board of Directors of OPKO Health, Inc. Since the primary content of the filing is the announcement of a change in the company's board of directors, it falls under the 'Board/Management Information' category.
2026-03-19 English
Immediate Report
Report Publication Announcement Classification · 95% confidence The document is a short filing (1756 characters) submitted to the Israel Securities Authority via the MAGNA system. It explicitly states 'Attached hereto is a report on Form 8-K' and provides a filename for the attachment. According to the 'Menu vs Meal' rule, since this is a short announcement notifying the public of an attached report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2026-03-19 English
Immediate Report
Regulatory Filings Classification · 95% confidence The document is a short announcement (approx. 1200 characters) regarding management's participation in an upcoming investor conference (Jefferies Biotech on the Beach Summit). It does not contain financial statements, proxy materials, or specific regulatory filings, but rather serves as a general corporate announcement regarding investor relations activities. As it does not fit into specific categories like earnings releases or reports, it falls under the general regulatory announcement category.
2026-02-27 English
Immediate Report
Regulatory Filings Classification · 95% confidence The document is a short regulatory filing (under 2,000 characters) from OPKO Health submitted to the Israel Securities Authority. It explicitly states 'Attached hereto is a report on OPKO Health to Participate in the Jefferies Biotech on the Beach Summit' and provides a filename for the attachment. Following the 'Menu vs Meal' rule, this is an announcement regarding the publication of a report/presentation rather than the presentation itself, making it a Report Publication Announcement (RPA).
2026-02-27 English
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Earnings Release Classification · 100% confidence The document is a Form 8-K filed with the SEC by OPKO Health, Inc. It contains an Item 2.02 disclosure regarding 'Results of Operations and Financial Condition' and includes an attached press release (Exhibit 99.1) detailing quarterly financial results, business highlights, and financial guidance. While it contains financial data, it is an official SEC filing (Form 8-K) used to announce earnings, which falls under the Earnings Release category in this classification system. Q4 2025
2026-02-27 English
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Report Publication Announcement Classification · 100% confidence The document is a short regulatory filing (under 2,000 characters) that explicitly states 'Attached hereto is a report on OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results' and provides a filename for the attachment. According to the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2026-02-27 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.